No. As of October 2026, H Lundbeck A/S (HLUN A.CO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. H Lundbeck A/S does not pass Musaffa's business and financial screening criteria.
H Lundbeck A/S is a DK-based company operating in Pharmaceuticals industry. H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. The company is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The firm operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.
H Lundbeck A/S HLUN A.CO
Last Updated: Oct 14, 12:00 AM·CSE
HLUN A.CO Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, H Lundbeck A/S is classified as not halal.